T1	Participants 236 395	children and adolescents with autistic disorder who were manifesting behaviors such as tantrums, aggression, self-injurious behavior, or a combination of these
T2	Participants 502 566	children and adolescents (aged 6-17 years) with autistic disorde
T3	Participants 569 637	Patients were randomly assigned (1:1) to flexibly dosed aripiprazole
T4	Participants 890 911	Ninety-eight patients
